The pay that Heather Bresch, chief executive officer of Mylan Inc., receives is under scrutiny by Congress as her company hikes prices for EpiPens.
The pay that Heather Bresch, chief executive officer of Mylan Inc., receives is under scrutiny by Congress as her company hikes prices for EpiPens. Andrew Harrer Bloomberg
The pay that Heather Bresch, chief executive officer of Mylan Inc., receives is under scrutiny by Congress as her company hikes prices for EpiPens. Andrew Harrer Bloomberg

Editorials

Another black eye for Pharma

August 24, 2016 2:05 PM

Comments

Videos